Title : Response to first-line chemotherapy in patients with non-small-cell lung cancer according to epidermal growth factor receptor and K-RAS mutation status.

Pub. Date : 2013 Nov

PMID : 23910066






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Among the patients with EGFR mutations, the disease control rate for docetaxel was higher than for gemcitabine-based therapy (P = .031). gemcitabine epidermal growth factor receptor Homo sapiens
2 In addition, docetaxel or vinorelbine showed a longer PFS than gemcitabine-based chemotherapy in patients with EGFR mutations (P = .033 and P = .028). gemcitabine epidermal growth factor receptor Homo sapiens
3 In patients with EGFR mutations, PFS for docetaxel and gemcitabine was higher than for vinorelbine-based chemotherapies. gemcitabine epidermal growth factor receptor Homo sapiens